Hydroquinidine

DB15300InvestigationalSmall molecule

Hydroquinidine is a medication indicated in the maintenance of a normal sinus rhythm, as well as the treatment and prevention of abnormal rhythm. Hydroquinidine is under investigation in clinical trial NCT00927732 (Hydroquinidine Versus Placebo in Patients With Brugada Syndrome).

Chemical structure of Hydroquinidine
Mechanism
Curator reviewed
Formula / weight
C20H26N2O2 · 326.44 g/mol (avg)

Resolves to

Compound
UNII8P68XPY4HGCAS1435-55-8ChEMBLCHEMBL531472
Clinical / RWD
RxNorm27220ATCC01BA13
Structure
InChIKeyLJOQGZACKSYWCH-LHHVKLHASA-NSMILES[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2CC)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12
Targets
Q14524SCN5A

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
155Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
7Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
12ContraindicationsEach with its own population and attribute set
Sign in
3Marketed productsAcross 2 countries and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Hydroquinidine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In